Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cipla
US Department of Justice
Mallinckrodt
Federal Trade Commission
Fuji
Boehringer Ingelheim
Fish and Richardson
QuintilesIMS

Generated: April 26, 2018

DrugPatentWatch Database Preview

FENOFIBRIC ACID Drug Profile

« Back to Dashboard

When do Fenofibric Acid patents expire, and what generic alternatives are available?

Fenofibric Acid is a drug marketed by Actavis Elizabeth, Alembic Pharms Ltd, Anchen Pharms, Impax Labs Inc, Lupin Ltd, and Mylan Pharms Inc. and is included in six NDAs.

The generic ingredient in FENOFIBRIC ACID is choline fenofibrate. There are one hundred and two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.
Drug patent expirations by year for FENOFIBRIC ACID
Pharmacology for FENOFIBRIC ACID
Synonyms for FENOFIBRIC ACID
017F890
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoicacid
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropionic acid
2-[4-(4-Chloro-benzoyl)-phenoxy]-2-methyl-propionic acid (Fenofibric acid)
2-[4-(4-Chlorobenzoyl)-phenoxy]-2-methylpropionic acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic Acid
2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic Acid (Fenofibric Acid)
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic acid, 95%
2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoic acid
2-methyl-((4'-4-chlorobenxoly)-2-phenoxy)propionic acid
2-methyl-((4'-p-chlorobenzoyl)-2-phenoxy)propionic acid
42017-89-0
4CH-014888
AB0011864
AB01563028_01
AC-22277
AC1L228K
AJ-08119
AK117112
AKOS015889489
alpha 1081
AN-6566
API0000561
API0025995
AX8069177
BDBM28700
BGF9MN2HU1
BRN 2058973
C17H15ClO4
CCG-213311
CCRIS 7302
CHEBI:83469
CHEMBL981
CL23223
CS-2965
D0NF1U
DB13873
DTXSID8041030
EINECS 255-626-9
F1011
feno-fibric acid
Fenofibrate impurity B, European Pharmacopoeia (EP) Reference Standard
Fenofibrate Related Compound B, United States Pharmacopeia (USP) Reference Standard
FENOFIBRIC ACID
Fenofibric acid, analytical standard
FNF Acid
FT-0082391
FT-0600402
GTPL2662
HY-B0760
I01-2052
J10251
KB-51864
KS-00000MR0
KS-1234
LF 153
LF 178 acid
LS-121251
M-1210
MCULE-1938576029
MFCD00792461
MolPort-000-002-475
MQOBSOSZFYZQOK-UHFFFAOYSA-N
NSC 281318
NSC-281318
NSC281318
OR026035
Procetofenic acid
Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-
Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-
RL03621
s4527
SC-15796
SCHEMBL16377
ST2416089
ST50998899
Trilipix
UNII-BGF9MN2HU1
W-106287
ZINC1984

US Patents and Regulatory Information for FENOFIBRIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200920-001 Oct 7, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200264-001 Sep 7, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705-002 May 12, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200913-002 Mar 25, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Accenture
Express Scripts
UBS
McKesson
Cerilliant
Argus Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.